Spectranetics has received CE Marking for its Stellarex 0.014 drug-coated angioplasty balloon (DCB).

The device is designed to treat small vessels, below-the-knee disease and critical limb ischemia in patients.

Stellarex is not available in the U.S. — Cynthia Jessup